On Sept. 22, 2020, Oxford Immunotec announced that it had entered into an extensive research collaboration with Public Health England and launched the ‘Evaluating Detection of SARS-CoV-2 antibodies using home test kits’ study (EDSAB-HOME), a cohort study of high risk (healthcare workers) and lower risk populations to provide rapid validation of SARS-CoV-2 (‘COVID-19’) testing kits.

With this collaboration, the Company contributed its T-SPOT Discovery SARS-CoV-2 testing kits for use in the trial.